4sight Health Roundup (for Healthcare Executives)

Will Trump's executive order aimed at lowering drug prices for consumers be a ripple or a bang? David W. Johnson and Julie Murchinson debate the issue on, “Critiquing Trump's Latest Plan to Lower Drug Prices,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.

President and CEO of Trilliant Health Hal Andrews shares his biggest takeaways from Trilliant’s new report, 2024 Trends Shaping the Health Economy. What made him pessimistic? What made him optimistic? Find out, "How Healthcare Revolutionaries Think With Hal Andrews," on the 4sight Health Roundup podcast.

Vertical integration and healthcare platforms. Are they good for healthcare consumers or just good for healthcare conglomerates? David W. Johnson and Julie Murchinson discuss the pros and cons and who benefits from them on, “Putting Together the Pieces,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.

New numbers are out, and they're not good. David W. Johnson and Julie Murchinson suggest some market-driven, private-sector innovations to reverse the negative trends in maternal mortality rates on, “Reversing the Trends in Maternal Mortality,” a special episode of the 4sight Health Roundup podcast, moderated by David Burda.

High administrative costs are a natural byproduct of our current healthcare system. David W. Johnson and Julie Murchinson critiqued three ideas to reduce them — and came up with a few of their own — on, “What Are the Best Options to Reduce Healthcare Administrative Costs?” the new episode of the 4sight Health Roundup podcast.

A new self-interested report on the sustainability of emergency care in the U.S. gets the problem right but the solution wrong. David W. Johnson and Julie Murchinson explain on, “Right Diagnosis, Wrong Treatment Plan,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.

What are the personalized medicine and market lessons from the fall of 23andMe? David W. Johnson and Julie Murchinson perform a postmortem on the failure of the direct-to-consumer genetic testing company on “Sequencing the Fallout from the 23andMe Collapse,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda. Listen.

Healthcare Revolutionary Julie Murchinson is known for calling out trends before they make the headlines, including GLP-1 drugs and GenAI's impact on healthcare. In this episode of the 4sight Health Roundup podcast, she sits down for an interview with 4sight Health's David Burda to talk about tech transformation, artificial intelligence and healthcare. Listen.

The COVID-19 pandemic marked its five-year anniversary this month. What did we learn about ourselves, society and the healthcare system? David W. Johnson and Julie Murchinson discuss the pandemic and the years since on, “Lingering Lessons Five Years After COVID,” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.

If the new administration drastically reduces budgeted Medicaid spending, how should states and the market respond? David W. Johnson and Julie Murchinson debated the issue on “Medicaid's Future: Disaster or Opportunity?” the new episode of the 4sight Health Roundup podcast, moderated by David Burda.